Sóvágó J - Search Results

1

[Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study].

Vas A, Sóvágó J, Halldin C, Sandell J, Karlsson P, Kárpáti E, Kiss B, Cselényi Z, Farde L, Gulyás B. Vas A, et al. Among authors: sovago j. Orv Hetil. 2002 Nov 24;143(47):2631-6. Orv Hetil. 2002. PMID: 12532649 Hungarian.

2

[Human positron emission tomography with oral 11C-vinpocetine].

Vas A, Christer H, Sóvágó J, Johan S, Cselényi Z, Kiss B, Kárpáti E, Lars F, Gulyás B. Vas A, et al. Among authors: sovago j. Orv Hetil. 2003 Nov 16;144(46):2271-6. Orv Hetil. 2003. PMID: 14702922 Clinical Trial. Hungarian.

3

PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects.

Gulyás B, Halldin C, Sandell J, Karlsson P, Sóvágó J, Kárpáti E, Kiss B, Vas A, Cselényi Z, Farde L. Gulyás B, et al. Among authors: sovago j. Acta Neurol Scand. 2002 Dec;106(6):325-32. doi: 10.1034/j.1600-0404.2002.01302.x. Acta Neurol Scand. 2002. PMID: 12460136 Clinical Trial.

4

Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.

Gulyás B, Halldin C, Sóvágó J, Sandell J, Cselényi Z, Vas A, Kiss B, Kárpáti E, Farde L. Gulyás B, et al. Among authors: sovago j. Eur J Nucl Med Mol Imaging. 2002 Aug;29(8):1031-8. doi: 10.1007/s00259-002-0823-4. Epub 2002 May 7. Eur J Nucl Med Mol Imaging. 2002. PMID: 12173017 Clinical Trial.

5

Cerebral uptake of [ethyl-11C]vinpocetine and 1-[11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study.

Gulyás B, Vas A, Halldin C, Sóvágó J, Sandell J, Olsson H, Fredriksson A, Stone-Elander S, Farde L. Gulyás B, et al. Among authors: sovago j. Nucl Med Biol. 2002 Oct;29(7):753-9. doi: 10.1016/s0969-8051(02)00319-0. Nucl Med Biol. 2002. PMID: 12381455

6

Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER.

Schou M, Halldin C, Sóvágó J, Pike VW, Gulyás B, Mozley PD, Johnson DP, Hall H, Innis RB, Farde L. Schou M, et al. Among authors: sovago j. Nucl Med Biol. 2003 Oct;30(7):707-14. doi: 10.1016/s0969-8051(03)00079-9. Nucl Med Biol. 2003. PMID: 14499328

7

A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey.

Finnema SJ, Seneca N, Farde L, Shchukin E, Sóvágó J, Gulyás B, Wikström HV, Innis RB, Neumeyer JL, Halldin C. Finnema SJ, et al. Among authors: sovago j. Nucl Med Biol. 2005 May;32(4):353-60. doi: 10.1016/j.nucmedbio.2005.01.007. Nucl Med Biol. 2005. PMID: 15878504

8

Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.

Schou M, Pike VW, Sóvágó J, Gulyás B, Gallagher PT, Dobson DR, Walter MW, Rudyk H, Farde L, Halldin C. Schou M, et al. Among authors: sovago j. Bioorg Med Chem. 2007 Jan 15;15(2):616-25. doi: 10.1016/j.bmc.2006.10.065. Epub 2006 Nov 2. Bioorg Med Chem. 2007. PMID: 17123820

9

Positron emission tomographic evaluation of the putative dopamine-D3 receptor ligand, [11C]RGH-1756 in the monkey brain.

Sóvágó J, Farde L, Halldin C, Langer O, Laszlovszky I, Kiss B, Gulyás B. Sóvágó J, et al. Neurochem Int. 2004 Oct;45(5):609-17. doi: 10.1016/j.neuint.2004.04.004. Neurochem Int. 2004. PMID: 15234102

10

Lack of effect of reserpine-induced dopamine depletion on the binding of the dopamine-D3 selective radioligand, [11C]RGH-1756.

Sóvágó J, Farde L, Halldin C, Schukin E, Schou M, Laszlovszky I, Kiss B, Gulyás B. Sóvágó J, et al. Brain Res Bull. 2005 Oct 15;67(3):219-24. doi: 10.1016/j.brainresbull.2005.06.034. Brain Res Bull. 2005. PMID: 16144658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters